The radiologically isolated syndrome: Take action when the unexpected is uncovered?

Journal of Neurology

Volumn 257, Issue 10, 2010, Pages 1602-1611

  Sellner, Johann ^a   Schirmer, Lucas ^a   Hemmer, Bernhard ^a   Mühlau, Mark ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Clinically isolated syndrome; Immunomodulation; Magnetic resonance imaging; Multiple sclerosis; Prognosis

Indexed keywords

GADOLINIUM;

ASYMPTOMATIC DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; EVOKED VISUAL RESPONSE; HUMAN; INCIDENTAL FINDING; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIOLOGICALLY ISOLATED SYNDROME; REVIEW; CENTRAL NERVOUS SYSTEM; COGNITIVE DEFECT; DISEASE COURSE; ELECTROENCEPHALOGRAPHY; EVOKED AUDITORY RESPONSE; METHODOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; STANDARD;

CENTRAL NERVOUS SYSTEM; COGNITION DISORDERS; DISEASE PROGRESSION; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS, AUDITORY; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS;

EID: 79952196948     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-010-5601-9     Document Type: Review

References (56)

1. Barkhof F, Filippi M, Miller DH, Scheltens P, Campi A, Polman CH, Comi G, Ader HJ, Losseff N, Valk J (1997) Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 120:2059-2069
2. Benedict RH, Fazekas F (2009) Benign or not benign MS. A role for routine neuropsychological assessment? Neurology 73:494-495
3. Bot JC, Barkhof F, Polman CH, Lycklama a Nijeholt GJ, de Groot V, Bergers E, Ader HJ, Castelijns JA (2004) Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examination. Neurology 62:226-233
4. Bourdette D, Simon J (2009) The radiologically isolated syndrome: is it very early multiple sclerosis? Neurology 72:780-781
5. Brex PA, Miszkiel KA, O'Riordan JI, Plant GT, Moseley IF, Thompson AJ, Miller DH (2001) Assessing the risk of early multiple sclerosis in patients with clinically isolated syndromes: the role of a follow up MRI. J Neurol Neurosurg Psychiatry 70:390-393
6. Butler MA, Bennett TL (2003) In search of a conceptualization of multiple sclerosis: a historical perspective. Neuropsychol Rev 13:93-112
7. Castaigne P, Lhermitte F, Escourolle R, Hauw JJ, Gray F, Lyon-Caen O (1981) Les scleroses en plaques asymptomatiques. Rev Neurol (Paris) 137:729-739
8. Comi G, Filippi M, Barkhof F, Durelli L, Edan G, Fernandez O, Hartung H, Seeldrayers P, Sorensen PS, Rovaris M, Martinelli V, Hommes OR (2001) Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study. Lancet 357:1576-1582
9. Compston A, Coles A (2008) Multiple sclerosis. Lancet 372:1502-1517
10. Confavreux C, Vukusic S (2008) The clinical epidemiology of multiple sclerosis. Neuroimaging Clin N Am 18:589-622
11. Engell T (1989) A clinical patho-anatomical study of clinically silent multiple sclerosis. Acta Neurol Scand 79:428-430
12. Ergun U, Ozer G, Sekercan S, Artan E, Kudiaki C, Ucler S, Coskun O, Inan L (2009) Headaches in the different phases of relapsing-remitting multiple sclerosis: a tendency for stabbing headaches during relapses. Neurologist 15:212-216
13. Feuillet L, Reuter F, Audoin B, Malikova I, Barrau K, Cherif AA, Pelletier J (2007) Early cognitive impairment in patients with clinically isolated syndrome suggestive of multiple sclerosis. Mult Scler 13:124-127
14. Fisniku LK, Brex PA, Altmann DR, Miszkiel KA, Benton CE, Lanyon R, Thompson AJ, Miller DH (2008) Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain 131:808-817
15. Frischer JM, Bramow S, Dal-Bianco A, Lucchinetti CF, Rauschka H, Schmidbauer M, Laursen H, Sorensen PS, Lassmann H (2009) The relation between inflammation and neuro-degeneration in multiple sclerosis brains. Brain 132:1175-1189
16. Gilbert JJ, Sadler M (1983) Unsuspected multiple sclerosis. Arch Neurol 40:533-536
17. Hakiki B, Goretti B, Portaccio E, Zipoli V, Amato MP (2008) 'Subclinical MS': follow-up of four cases. Eur J Neurol 15:858-861
18. Hemmer B, Nessler S, Zhou D, Kieseier B, Hartung HP (2006) Immunopathogenesis and immunotherapy of multiple sclerosis. Nat Clin Pract Neurol 2:201-211
19. Hutchinson M (2009) Predicting and preventing the future: actively managing multiple sclerosis. Pract Neurol 9:133-143, (discussion 144)
20. Jacobi C, Hahnel S, Martinez-Torres F, Rieger S, Juttler E, Heiland S, Jarius S, Meyding-Lamade U, Storch-Hagenlocher B, Wildemann B (2008) Prospective combined brain and spinal cord MRI in clinically isolated syndromes and possible early multiple sclerosis: impact on dissemination in space and time. Eur J Neurol 15:1359-1364
21. Jacobs LD, Beck RW, Simon JH, Kinkel RP, Brownscheidle CM, Murray TJ, Simonian NA, Slasor PJ, Sandrock AW (2000) Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. N Engl J Med 343:898-904
22. Kappos L, Freedman MS, Polman CH, Edan G, Hartung HP, Miller DH, Montalban X, Barkhof F, Radu EW, Metzig C, Bauer L, Lanius V, Sandbrink R, Pohl C (2009) Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial. Lancet Neurol 8:987-997
23. Kobelt G, Berg J, Lindgren P, Kerrigan J, Russell N, Nixon R (2006) Costs and quality of life of multiple sclerosis in the United Kingdom. Eur J Health Econ 7 S2:S96-104
24. Kurne A, Isikay IC, Karlioguz K, Kalyoncu U, Aydin OF, Calguneri M, Karabudak R (2008) A clinically isolated syndrome: a challenging entity: multiple sclerosis or collagen tissue disorders: clues for differentiation. J Neurol 255:1625-1635
25. Lebrun C, Bensa C, Debouverie M, De Seze J, Wiertlievski S, Brochet B, Clavelou P, Brassat D, Labauge P, Roullet E (2008) Unexpected multiple sclerosis: follow-up of 30 patients with magnetic resonance imaging and clinical conversion profile. J Neurol Neurosurg Psychiatry 79:195-198
26. Lebrun C, Bensa C, Debouverie M, Wiertlevski S, Brassat D, de Seze J, Rumbach L, Pelletier J, Labauge P, Brochet B, Tourbah A, Clavelou P (2009) Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients. Arch Neurol 66:841-846
27. Lyoo IK, Seol HY, Byun HS, Renshaw PF (1996) Unsuspected multiple sclerosis in patients with psychiatric disorders: a magnetic resonance imaging study. J Neuropsychiatry Clin Neurosci 8:54-59
28. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121-127
29. Miller D, Barkhof F, Montalban X, Thompson A, Filippi M (2005) Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis. Lancet Neurol 4:281-288
30. Miller D, McDonald I, Smith K (2006) The diagnosis of multiple sclerosis. In: Compston A (ed) McAlpine's multiple sclerosis. Churchill Livingstone Elsevier, Cambridge, pp 347-388
31. Miller DH, Weinshenker BG, Filippi M, Banwell BL, Cohen JA, Freedman MS, Galetta SL, Hutchinson M, Johnson RT, Kappos L, Kira J, Lublin FD, McFarland HF, Montalban X, Panitch H, Richert JR, Reingold SC, Polman CH (2008) Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler 14:1157-1174
32. Morris Z, Whiteley WN, Longstreth WT Jr, Weber F, Lee YC, Tsushima Y, Alphs H, Ladd SC, Warlow C, Wardlaw JM, Al-Shahi Salman R (2009) Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 339:b3016
33. Mowry EM, Pesic M, Grimes B, Deen S, Bacchetti P, Waubant E (2009) Demyelinating events in early multiple sclerosis have inherent severity and recovery. Neurology 72:602-608
34. Neema M, Goldberg-Zimring D, Guss ZD, Healy BC, Guttmann CR, Houtchens MK, Weiner HL, Horsfield MA, Hackney DB, Alsop DC, Bakshi R (2009) 3 T MRI relaxometry detects T2 prolongation in the cerebral normal-appearing white matter in multiple sclerosis. Neuroimage 46:633-641
35. Okuda DT (2009) Unanticipated demyelinating pathology of the CNS. Nat Rev Neurol 5:591-597
36. Okuda DT, Mowry EM, Beheshtian A, Waubant E, Baranzini SE, Goodin DS, Hauser SL, Pelletier D (2009) Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome. Neurology 72:800-805
37. Pittock SJ, McClelland RL, Mayr WT, Jorgensen NW, Weinshenker BG, Noseworthy J, Rodriguez M (2004) Clinical implications of benign multiple sclerosis: a 20-year population-based follow-up study. Ann Neurol 56:303-306
38. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O'Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 58:840-846
39. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227-231
40. Putzki N, Pfriem A, Limmroth V, Yaldizli O, Tettenborn B, Diener HC, Katsarava Z (2009) Prevalence of migraine, tension-type headache and trigeminal neuralgia in multiple sclerosis. Eur J Neurol 16:262-267
41. Ranjeva JP, Audoin B, Au Duong MV, Confort-Gouny S, Malikova I, Viout P, Soulier E, Pelletier J, Cozzone PJ (2006) Structural and functional surrogates of cognitive impairment at the very early stage of multiple sclerosis. J Neurol Sci 245:161-167
42. Rocca MA, Ceccarelli A, Falini A, Colombo B, Tortorella P, Bernasconi L, Comi G, Scotti G, Filippi M (2006) Brain gray matter changes in migraine patients with T2-visible lesions: a 3-T MRI study. Stroke 37:1765-1770
43. Schirmer L, Albert M, Buss A, Schulz-Schaeffer WJ, Antel JP, Brück W, Stadelmann C (2009) Substantial early, but non-progressive neuronal loss in MS spinal cord. Ann Neurol 66:698-704
44. Sellner J, Greeve I, Findling O, Kamm CP, Minten C, Engelhardt B, Grandgirard D, Leib SL, Mattle HP (2008) Effect of inter-feron-beta and atorvastatin on Th1/Th2 cytokines in multiple sclerosis. Neurochem Int 53:17-21
45. Sellner J, Greeve I, Leib SL, Mattle HP (2008) Atorvastatin does not alter interferon Beta-induced changes of serum matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in patients with multiple sclerosis. Arch Neurol 65:672-674
46. Simioni S, Ruffieux C, Bruggimann L, Annoni JM, Schluep M (2007) Cognition, mood and fatigue in patients in the early stage of multiple sclerosis. Swiss Med Wkly 137:496-501
47. Siva A, Saip S, Altintas A, Jacob A, Keegan B, Kantarci O (2009) Multiple sclerosis risk in radiologically uncovered asymptomatic possible inflammatory-demyelinating disease. Mult Scler 15:918-927
48. Thrower BW (2007) Clinically isolated syndromes: predicting and delaying multiple sclerosis. Neurology 68:S12-S15
49. Tienari PJ, Salonen O, Wikstrom J, Valanne L, Palo J (1992) Familial multiple sclerosis: MRI findings in clinically affected and unaffected siblings. J Neurol Neurosurg Psychiatry 55:883-886
50. Tintore M (2008) Rationale for early intervention with immunomodulatory treatments. J Neurol 255 (Suppl 1):37-43
51. Tintore M, Rovira A, Martinez MJ, Rio J, Diaz-Villoslada P, Brieva L, Borras C, Grive E, Capellades J, Montalban X (2000) Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. AJNR Am J Neuroradiol 21:702-706
52. Tintore M, Rovira A, Rio J, Nos C, Grive E, Sastre-Garriga J, Pericot I, Sanchez E, Comabella M, Montalban X (2003) New diagnostic criteria for multiple sclerosis: application in first demyelinating episode. Neurology 60:27-30
53. Tintore M, Rovira A, Rio J, Nos C, Grive E, Tellez N, Pelayo R, Comabella M, Sastre-Garriga J, Montalban X (2006) Baseline MRI predicts future attacks and disability in clinically isolated syndromes. Neurology 67:968-972
54. Tintore M, Rovira A, Rio J, Tur C, Pelayo R, Nos C, Tellez N, Perkal H, Comabella M, Sastre-Garriga J, Montalban X (2008) Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis? Neurology 70:1079-1083
55. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L (1998) Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338:278-285
56. Weiner HL (2009) The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease? Ann Neurol 65:239-248